Why Are Women Prone to Restless Legs Syndrome?

International Journal of Environmental Research and Public Health - Tập 17 Số 1 - Trang 368
Mary V. Seeman1
1Department of Psychiatry, University of Toronto, Toronto, ON M5G 1L7, Canada

Tóm tắt

Restless legs syndrome is a relatively common neurologic disorder considerably more prevalent in women than in men. It is characterized by an inactivity-induced, mostly nocturnal, uncomfortable sensation in the legs and an urge to move them to make the disagreeable sensation disappear. Some known genes contribute to this disorder and the same genes contribute to an overlapping condition—periodic leg movements that occur during sleep and result in insomnia. Dopamine and glutamate transmission in the central nervous system are involved in the pathophysiology, and an iron deficiency has been shown in region-specific areas of the brain. A review of the literature shows that pregnant women are at particular risk and that increased parity is a predisposing factor. Paradoxically, menopause increases the prevalence and severity of symptoms. This implies a complex role for reproductive hormones. It suggests that changes rather than absolute levels of estrogen may be responsible for the initiation of symptoms. Both iron (at relatively low levels in women) and estrogen (at relatively high oscillating levels in women) influence dopamine and glutamate transmission, which may help to explain women’s vulnerability to this condition. The syndrome is comorbid with several disorders (such as migraine, depression, and anxiety) to which women are particularly prone. This implies that the comorbid condition or its treatment, or both, contribute to the much higher prevalence in women than in men of restless legs syndrome.

Từ khóa


Tài liệu tham khảo

Allen, 2019, New insights into the neurobiology of restless legs syndrome, Neuroscientist, 25, 113, 10.1177/1073858418791763

Malkani, 2019, Update on restless legs syndrome: From mechanisms to treatment, Curr. Neurol. Neurosci. Rep., 19, 54, 10.1007/s11910-019-0965-4

Becker, 2014, Mood disorders in restless legs syndrome (Willis-Ekbom disease), J. Clin. Psychiatry, 75, 679, 10.4088/JCP.13r08692

Cho, 2009, Restless legs syndrome in a community sample of Korean adults: Prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders, Sleep, 32, 1069

Hornyak, 2010, Depressive disorders in restless legs syndrome, CNS Drugs, 24, 89, 10.2165/11317500-000000000-00000

Allen, 2014, Restless legs syndrome/Willis-Ekbom disease diagnostic criteria: Updated International Restless Legs Syndrome Study Group (IRLSSG) consensus criteria—History, rationale, description, and significance, Sleep Med., 15, 860, 10.1016/j.sleep.2014.03.025

Kohnen, 2016, Rating of daytime and nighttime symptoms in RLS: Validation of the RLS-6 scale of restless legs syndrome/Willis–Ekbom disease, Sleep Med., 20, 116, 10.1016/j.sleep.2015.10.014

Gupta, 2014, Clinical presentation of restless legs syndrome: Does the gender matter?, Sleep Biol. Rhythm., 12, 180, 10.1111/sbr.12059

Stefani, 2018, Ethnic differences in periodic limb movements during sleep in patients with restless legs syndrome: A preliminary cross-sectional study of Austrian and Japanese clinical population, Sleep Biol. Rhythm., 16, 345, 10.1007/s41105-018-0159-5

Tison, 2005, Epidemiology of restless legs syndrome in French adults: A nationwide survey: The Instant Study, Neurology, 65, 239, 10.1212/01.wnl.0000168910.48309.4a

Nilsson, 2008, Restless legs syndrome among women: Prevalence, co-morbidity and possible relationship to menopause, Climacteric, 11, 422, 10.1080/13697130802359683

Ohayon, 2012, Epidemiology of restless legs syndrome: A synthesis of the literature, Sleep Med. Rev., 16, 283, 10.1016/j.smrv.2011.05.002

Trenkwalder, 2016, Restless legs syndrome associated with major diseases: A systematic review and new concept, Neurology, 86, 1336, 10.1212/WNL.0000000000002542

Arzhan, S., Roumelioti, M.-E., and Unruh, M.L. (2019). Itch and ache on dialysis: New approaches to manage uremic pruritis and restless legs. Blood Purif.

Xiong, 2007, Canadian restless legs syndrome twin study, Neurology, 68, 1631, 10.1212/01.wnl.0000261016.90374.fd

Allen, 2015, Restless leg syndrome/Willis-Ekbom disease pathophysiology, Sleep Med. Clin., 10, 207, 10.1016/j.jsmc.2015.05.022

Sarayloo, 2019, MEIS1 and restless legs syndrome: A comprehensive review, Front. Neurol., 10, 935, 10.3389/fneur.2019.00935

2018, Genetics of restless legs syndrome: An update, Sleep Med. Rev., 39, 108, 10.1016/j.smrv.2017.08.002

Schormair, 2017, Identification of novel risk loci for restless legs syndrome in genome-wide association studies in individuals of European ancestry: A meta-analysis, Lancet Neurol., 16, 898, 10.1016/S1474-4422(17)30327-7

Anderson, 2017, Current understanding of iron homeostasis, Am. J. Clin. Nutr., 106, 1559, 10.3945/ajcn.117.155804

Kolukisa, 2016, Restless leg syndrome/Willis-Ekbom disease in women with iron deficiency anemia, Ideggyog. Szle., 69, 356, 10.18071/isz.69.0356

2019, Frequency of iron deficiency anemia in pregnant and non-pregnant women suffering from restless legs syndrome, Hematology, 24, 263, 10.1080/16078454.2018.1560935

Earley, 2014, Altered brain iron homeostasis and dopaminergic function in restless legs syndrome, Sleep Med., 15, 1288, 10.1016/j.sleep.2014.05.009

Jellen, 2013, Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice, Neuroscience, 252, 13, 10.1016/j.neuroscience.2013.07.058

Kanga, 2007, Characteristics and clinical correlates of restless legs syndrome in schizophrenia, Prog. Neuro Psychopharmacol. Biol. Psychiatry, 31, 1078, 10.1016/j.pnpbp.2007.03.011

2019, Neurochemical features of idiopathic restless legs syndrome, Sleep Med. Rev., 45, 70, 10.1016/j.smrv.2019.03.006

Yepes, 2017, Targeting hypersensitive corticostriatal terminals in restless legs syndrome, Ann. Neurol., 82, 951, 10.1002/ana.25104

Gupta, 2018, Willis-Ekbom disease/restless legs syndrome in patients with opioid withdrawal, Sleep Med., 45, 39, 10.1016/j.sleep.2017.09.028

Whone, 2005, The role of opioids in restless legs syndrome: An [11C]diprenorphine PET study, Brain, 128, 906, 10.1093/brain/awh441

Karroum, 2020, TOX3 gene variant could be associated with painful restless legs, Sleep Med., 65, 4, 10.1016/j.sleep.2019.07.003

Winkelman, 2013, Sensory symptoms in restless legs syndrome: The enigma of pain, Sleep Med., 14, 934, 10.1016/j.sleep.2013.05.017

Baker, 2017, Movement disorders in women, Semin. Neurol., 37, 653, 10.1055/s-0037-1608845

Kulkarni, 2019, Estrogens and SERMS as adjunctive treatments for schizophrenia, Front. Neuroendocrinol., 53, 100743, 10.1016/j.yfrne.2019.03.002

Chen, 2018, Prevalence of restless legs syndrome during pregnancy: A systematic review and meta-analysis, Sleep Med. Rev., 40, 43, 10.1016/j.smrv.2017.10.003

Gupta, 2015, Restless legs syndrome and pregnancy: Prevalence, possible pathophysiological mechanisms and treatment, Acta Neurol. Scand., 133, 320, 10.1111/ane.12520

Makrani, 2018, Prevalence of restless legs syndrome in pregnant women: A meta-analysis, Sleep Biol. Rhythm., 16, 3, 10.1007/s41105-017-0126-6

Manconi, 2012, When gender matters: Restless legs syndrome. Report of the “RLS and woman” workshop endorsed by the European RLS Study Group, Sleep Med. Rev., 16, 297, 10.1016/j.smrv.2011.08.006

Miller, 2018, Gender differences in obstructive sleep apnoea, insomnia and restless legs syndrome in adults—What do we know? A clinical update, Sleep Med. Rev., 38, 28, 10.1016/j.smrv.2017.03.003

Ulfberg, 2014, Periodic limb movements are associated with vasomotor symptoms, J. Clin. Sleep Med., 10, 15, 10.5664/jcsm.3348

Innes, 2016, The relationship of restless legs syndrome to history of pregnancy-induced hypertension, J. Womens Health, 25, 397, 10.1089/jwh.2015.5484

Li, 2018, Prospective study of restless legs syndrome and total and cardiovascular mortality among women, Neurology, 90, 135, 10.1212/WNL.0000000000004814

Li, 2012, Association of multiple sclerosis with restless legs syndrome and other sleep disorders in women, Neurology, 78, 1500, 10.1212/WNL.0b013e3182553c5b

Hoffmann, 2014, Multimorbidity and the risk of restless legs syndrome in 2 prospective cohort studies, Neurology, 82, 2026, 10.1212/WNL.0000000000000470

Yang, 2018, Prevalence of restless legs syndrome in individuals with migraine: A systematic review and meta-analysis of observational studies, Neurol. Sci., 39, 1927, 10.1007/s10072-018-3527-7

Aggarwal, 2010, Restless leg syndrome associated with olanzapine: A case series, Curr. Drug Saf., 5, 129, 10.2174/157488610790936187

Kang, 2009, Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine, J. Psychopharmacol., 23, 597, 10.1177/0269881108091876

Patatanian, 2018, Drug-induced restless legs syndrome, Ann. Pharmacother., 52, 662, 10.1177/1060028018760296

Rottach, 2008, Restless legs syndrome as side effect of second generation antidepressants, J. Psychiatr. Res., 43, 70, 10.1016/j.jpsychires.2008.02.006

Siddiqui, 2018, Restless legs syndrome associated with quetiapine in elderly patient, Sleep Hypn., 20, 140

Zucconi, 2018, An update on the treatment of restless legs syndrome/Willis-Ekbom disease: Prospects and challenges, Expert Rev. Neurother., 18, 705, 10.1080/14737175.2018.1510773

Winkelmann, 2018, Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (revised 2017), Mov. Disord., 33, 1077, 10.1002/mds.27260

Rizzo, 2009, Dopamine agonists restore cortical plasticity in patients with idiopathic restless legs syndrome, Mov. Disord., 24, 710, 10.1002/mds.22436

Allen, 2018, Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/Willis-Ekbom disease in adults and children: An IRLSSG task force report, Sleep Med., 41, 27, 10.1016/j.sleep.2017.11.1126

Avni, 2019, Iron supplementation for restless legs syndrome—A systematic review and meta-analysis, Eur. J. Intern. Med., 63, 34, 10.1016/j.ejim.2019.02.009

Carlos, K., Prado, G.F., Teixeira, C.D., Conti, C., de Oliveira, M.M., Prado, L.B., and Carvalho, L.B.C. (2017). Benzodiazepines for restless legs syndrome. Cochrane Database Syst. Rev.

Silber, 2018, The appropriate use of opioids in the treatment of refractory restless legs syndrome, Mayo Clin. Proc., 93, 59, 10.1016/j.mayocp.2017.11.007

Trenkwalder, 2017, Pain, opioids, and sleep: Implications for restless legs syndrome treatment, Sleep Med., 31, 78, 10.1016/j.sleep.2016.09.017

Cederberg, 2018, Magnitude and duration of acute-exercise intensity effects on symptoms of restless legs syndrome: A pilot study, Sleep Biol. Rhythm., 16, 337, 10.1007/s41105-018-0158-6

Seeman, N., and Seeman, M.V. (2020). An anonymous survey method for obtaining sensitive, personal, or embarrassing information in the context of mental illness stigma. SAGE Res. Methods Cases, in press.

Roder-De Wan, S., Gage, A.D., Hirschhorn, L.R., Twum-Danso, N.A.Y., Liljestrand, J., Asante-Shongwe, K., Rodríguez, V., Yahya, T., and Kruk, M.E. (2019). Expectations of healthcare quality: A cross-sectional study of internet users in 12 low-and middle-income countries. PLoS Med., 16.

Thông tin
Thông tin xuất bản

International Journal of Environmental Research and Public Health

Tập 17 Số 1

368

Thông tin tác giả